Workflow
111 Reschedules Third Quarter 2024 Unaudited Financial Results Announcement to November 27, 2024 - Conference Call to Follow
YI111(YI) Prnewswire·2024-11-04 11:00

Core Viewpoint - 111, Inc. is set to release its unaudited financial results for Q3 2024 earlier than previously scheduled, now on November 27, 2024, before U.S. market opens [1] Group 1: Financial Results Announcement - The release of unaudited financial results for the third quarter ended September 30, 2024, will occur before the U.S. market opens on November 27, 2024, instead of November 28, 2024 [1] - An earnings conference call will be hosted by the management team at 7:30 AM U.S. Eastern Time on November 27, 2024 [2] Group 2: Conference Call Details - Participants must register online in advance to receive dial-in information, including the passcode and unique access PIN [2] - A live and archived webcast of the conference call will be available on the company's website [3] - A telephone replay of the call will be accessible until December 4, 2024 [3] Group 3: Company Overview - 111, Inc. is a leading tech-enabled healthcare platform in China, focused on reshaping the healthcare value chain by digitally empowering both upstream and downstream sectors [4] - The company provides better access to pharmaceutical products and healthcare services through its online retail pharmacy, 1 Pharmacy, and its offline virtual pharmacy network [4] - Online healthcare services are offered through its internet hospital, 1 Clinic, which includes online consultations and electronic prescriptions [4] - The company operates the largest virtual pharmacy network in China, enabling offline pharmacies to enhance customer service with cloud-based solutions [4] - 111, Inc. also provides an omni-channel drug commercialization platform, offering services like digital marketing and data analytics to strategic partners [4]